
Victoria Murphy
Examiner (ID: 13771)
| Most Active Art Unit | 3785 |
| Art Unit(s) | 3782, 3778, 4163, 3785, 4100, OPT, 4118 |
| Total Applications | 369 |
| Issued Applications | 204 |
| Pending Applications | 41 |
| Abandoned Applications | 126 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11318539
[patent_doc_number] => 09517274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => 'Glycoconjugation processes and compositions'
[patent_app_type] => utility
[patent_app_number] => 14/420822
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24006
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420822
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420822 | Glycoconjugation processes and compositions | Aug 11, 2013 | Issued |
Array
(
[id] => 10897606
[patent_doc_number] => 08920816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Apparatus and method for treating a neuromuscular defect'
[patent_app_type] => utility
[patent_app_number] => 13/952965
[patent_app_country] => US
[patent_app_date] => 2013-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 5299
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952965
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952965 | Apparatus and method for treating a neuromuscular defect | Jul 28, 2013 | Issued |
Array
(
[id] => 10275214
[patent_doc_number] => 20150160211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'METHOD OF DETECTING OXA-048 CARBAPENEMASE PRODUCING BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 14/412315
[patent_app_country] => US
[patent_app_date] => 2013-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5204
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412315 | Method of detecting OXA-048 carbapenemase producing bacteria | Jul 28, 2013 | Issued |
Array
(
[id] => 10078306
[patent_doc_number] => 09116151
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-08-25
[patent_title] => 'Detection plate for ATP-bioluminescence immunoassay and method of manufacturing'
[patent_app_type] => utility
[patent_app_number] => 13/952193
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 10
[patent_no_of_words] => 7338
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952193
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952193 | Detection plate for ATP-bioluminescence immunoassay and method of manufacturing | Jul 25, 2013 | Issued |
Array
(
[id] => 10070865
[patent_doc_number] => 09109212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Method for enhancing extracellular secretion of recombinant proteins in Escherichia coli by co-expressing Thermobifida fusca cutinase'
[patent_app_type] => utility
[patent_app_number] => 13/935519
[patent_app_country] => US
[patent_app_date] => 2013-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 3840
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935519
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935519 | Method for enhancing extracellular secretion of recombinant proteins in Escherichia coli by co-expressing Thermobifida fusca cutinase | Jul 3, 2013 | Issued |
Array
(
[id] => 9995462
[patent_doc_number] => 09040055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Conjugation of streptococcal capsular saccharides'
[patent_app_type] => utility
[patent_app_number] => 13/912919
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 15749
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13912919
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/912919 | Conjugation of streptococcal capsular saccharides | Jun 6, 2013 | Issued |
Array
(
[id] => 9054116
[patent_doc_number] => 20130251830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'THERAPEUTIC TREATMENTS USING BOTULINUM NEUROTOXIN'
[patent_app_type] => utility
[patent_app_number] => 13/900067
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13661
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900067
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900067 | THERAPEUTIC TREATMENTS USING BOTULINUM NEUROTOXIN | May 21, 2013 | Abandoned |
Array
(
[id] => 11177970
[patent_doc_number] => 09409956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/402457
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 9141
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402457
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402457 | Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof | May 21, 2013 | Issued |
Array
(
[id] => 9162266
[patent_doc_number] => 20130310543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'TOXIN GENES AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/893801
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16610
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893801
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/893801 | TOXIN GENES AND METHODS FOR THEIR USE | May 13, 2013 | Abandoned |
Array
(
[id] => 9015594
[patent_doc_number] => 20130230558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'ONE DOSE VACCINATION AGAINST MYCOPLASMA INFECTIONS OF PIGS'
[patent_app_type] => utility
[patent_app_number] => 13/869574
[patent_app_country] => US
[patent_app_date] => 2013-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8186
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869574
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/869574 | One dose vaccination against Mycoplasma infections of pigs | Apr 23, 2013 | Issued |
Array
(
[id] => 10077507
[patent_doc_number] => 09115350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'Carrier for targeting nerve cells'
[patent_app_type] => utility
[patent_app_number] => 13/867740
[patent_app_country] => US
[patent_app_date] => 2013-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7743
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13867740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/867740 | Carrier for targeting nerve cells | Apr 21, 2013 | Issued |
Array
(
[id] => 9160902
[patent_doc_number] => 20130309179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTIS ASSOCIATED WITH PORPHYROMONAS GINGIVALIS'
[patent_app_type] => utility
[patent_app_number] => 13/852272
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15273
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13852272
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/852272 | Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis | Mar 27, 2013 | Issued |
Array
(
[id] => 9041670
[patent_doc_number] => 20130244307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'COMPOSITIONS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/848909
[patent_app_country] => US
[patent_app_date] => 2013-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 64837
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848909
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/848909 | Compositions relating to a mutant Clostridium difficile toxin and methods thereof | Mar 21, 2013 | Issued |
Array
(
[id] => 9445185
[patent_doc_number] => 20140116353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'FUIDI HERD MANAGEMENT AND RISK STRATIFICATION METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/839322
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 36292
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13839322
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/839322 | FUIDI HERD MANAGEMENT AND RISK STRATIFICATION METHODS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9108835
[patent_doc_number] => 20130281967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'APPARATUS AND METHOD FOR TREATING A NEUROMUSCULAR DEFECT'
[patent_app_type] => utility
[patent_app_number] => 13/788322
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7347
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13788322
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/788322 | Apparatus and method for treating a neuromuscular defect | Mar 6, 2013 | Issued |
Array
(
[id] => 9685345
[patent_doc_number] => 20140242110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'Dose, localization, and formulation of botulinum toxins in skin and muscle'
[patent_app_type] => utility
[patent_app_number] => 13/815399
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5600
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815399
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/815399 | Dose, localization, and formulation of botulinum toxins in skin and muscle | Feb 27, 2013 | Abandoned |
Array
(
[id] => 9589083
[patent_doc_number] => 08778623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Compositions and methods of using differentiated cells sensitized to botulinum neurotoxin'
[patent_app_type] => utility
[patent_app_number] => 13/779972
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5360
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13779972
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/779972 | Compositions and methods of using differentiated cells sensitized to botulinum neurotoxin | Feb 27, 2013 | Issued |
Array
(
[id] => 9003053
[patent_doc_number] => 20130224178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases'
[patent_app_type] => utility
[patent_app_number] => 13/768665
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 64863
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768665
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768665 | Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases | Feb 14, 2013 | Abandoned |
Array
(
[id] => 11388747
[patent_doc_number] => 09549978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Amino acid sequences for controlling pathogens'
[patent_app_type] => utility
[patent_app_number] => 14/346562
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 7773
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346562
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346562 | Amino acid sequences for controlling pathogens | Sep 30, 2012 | Issued |
Array
(
[id] => 9670994
[patent_doc_number] => 20140234857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR TOXIGENICITY TESTING'
[patent_app_type] => utility
[patent_app_number] => 14/347074
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13510
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347074
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/347074 | Compositions and methods for toxigenicity testing | Sep 27, 2012 | Issued |